2011 Clinical Trials Collective 
Project CBD
MARCH 21, 2023
That’s what appeared to happen in rats injected with the synthetic CB1 agonists WIN55,212‐2 and CP55,940 in a 2010 study 4 and THC and CBD in a 1:1 ratio in a 2011 follow-up study. While the collective evidence to date is mixed and inconclusive, it’s also incomplete. 180 (2011): 75-84. Hearing research vol. doi:10.1016/j.heares.2010.05.015
Veriheal
FEBRUARY 9, 2023
A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures. Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. What Is an MRI?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 10, 2021
This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. 4 Pain 2011 Apr;152(4):717-725. (“Shanti”), and all its assets focused on psychedelic MDMA-based drug development.
Greencamp
FEBRUARY 17, 2019
Irritable bowel syndrome (IBS) is a collection of symptoms which create discomfort in the abdominal area, resulting in the inflammation of the digestive tract. Cannabis research still has a long way to go regarding this topic, and it will take more clinical trials to fully understand how cannabis helps with IBS. What is IBS?
Cannabis Law Report
JULY 28, 2021
We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” ” Next Steps.
Cannabis Law Report
NOVEMBER 24, 2021
2015 ; Kaiser 2011 ; Mortensen et al. Data collection. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. Kaiser CL (2011) Medical issue or policy? ML was responsible for the coding categories, data collection, and analysis.
The Cannigma
FEBRUARY 11, 2021
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. I know how to collect data. You know, started doing clinical trials through Zelda Therapeutics, and all the other things I’ve done. All I’m doing is collecting the data.
Expert insights. Personalized for you.
144 
Let's personalize your content